QA: CANNAPHARMARX INC. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001081938_2023_CANNAPHARMARX_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Liabilities', 'missing_ratio': 4.393937403352601e-08, 'aggregate_val': 22758632, 'exp_sum': 22758631, 'exp_to_value': {'LiabilitiesCurrent': 17165154, 'LiabilitiesNoncurrent': 0, 'remainder_Liabilities': 5593477}}

Graph

Absolute values for 0001081938, CANNAPHARMARX INC.

  xvar xval
0 AssetsCurrent 100,014
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 107,780
3 remainder_Assets 5,206,382
4 LiabilitiesCurrent 17,165,154
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 5,593,478
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,226,668
9 ResearchAndDevelopmentExpense 0
10 remainder_Expenses 2,985,141
11 remainder_Revenues 0
12 remainder_NetIncome -3,319,211
13 remainder_ComprehensiveNetIncome 612,335
  yvar yval
0 Assets 5,414,176
1 Liabilities 22,758,632
2 Expenses 5,211,809
3 Revenues 0
4 StockholdersEquity -17,344,456
5 NetIncome -8,531,020
6 ComprehensiveNetIncome -8,224,852
7 BaseVar 18,658,082
8 EconomicCapitalRatio -2.70

Edgar->Model Mapping

Feature Distribution

Change over Time